GeneCapture
Huntsville, US · Delaware corporation
Founders & leadership
KC
Krishnan ChitturDirector
PS
Peggy SammonExecutive Officer, Director
TN
Tim NewellDirector
MC
Michael ChambersDirector
Reported raises · per SEC filings
Form D private placements▶$50KraisedFeb 2026 · 2 investors · OtherRule 506(b)
▶$50KraisedFeb 2026 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Tim NewellDirector
- Krishnan ChitturDirector
- Michael ChambersDirector
- Peggy SammonExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $50K
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedDec 2024 · 1 investors · OtherRule 506(b)
▶$500KraisedDec 2024 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Krishnan ChitturDirector
- Tim NewellDirector
- Michael ChambersDirector
- Peggy SammonExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $500K
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedSep 2021 · 1 investors · OtherRule 506(b)
▶$1.2MraisedSep 2021 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Michael ChambersDirector
- Tim NewellDirector
- Peggy SammonExecutive Officer, Director
- Krishnan ChitturExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $1.2M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$125KraisedSep 2020 · 2 investors · OtherRule 506(c)
▶$125KraisedSep 2020 · 2 investors · Other
Rule 506(c)Officers, directors & promoters on the filing
- Michael ChambersDirector
- Peggy SammonExecutive Officer, Director
- Krishnan ChitturDirector
- Offering amount
- $381.6K
- Amount sold
- $125K
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$38.4KraisedJun 2019 · 3 investors · OtherRule 506(b)
▶$38.4KraisedJun 2019 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Michael ChambersDirector
- Krishnan ChitturExecutive Officer, Director
- Peggy SammonExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $38.4K
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$150KraisedJun 2018 · 2 investors · BiotechnologyRule 506(b)
▶$150KraisedJun 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael ChambersDirector
- Krishnan ChitturExecutive Officer, Director
- Peggy SammonExecutive Officer, Director
- Offering amount
- $150K
- Amount sold
- $150K
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$55KraisedOct 2017 · 3 investors · OtherRule 506(b)
▶$55KraisedOct 2017 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Peggy SammonExecutive Officer, Director
- Michael ChambersDirector
- Krishnan ChitturExecutive Officer, Director
- Offering amount
- $169.3K
- Amount sold
- $55K
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$110.7KraisedMay 2017 · 4 investors · OtherRule 506(b)
▶$110.7KraisedMay 2017 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Michael ChambersDirector
- Peggy SammonExecutive Officer, Director
- Krishnan ChitturExecutive Officer, Director
- Offering amount
- $280K
- Amount sold
- $110.7K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 7 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of DefenseDefense Health Program | Phase II | 2021 | $1.1M |
| Department of DefenseOffice for Chemical and Biological Defense | Phase II | 2021 | $999.8K |
| U.S. Air ForceAir Force | Phase II | 2020 | $284.8K |
| Department of DefenseDefense Health Program | Phase I | 2020 | $250K |
| U.S. Air ForceAir Force | Phase I | 2019 | $49.8K |
| Department of DefenseOffice for Chemical and Biological Defense | Phase IISTTR | 2018 | $994.2K |
| Department of DefenseOffice for Chemical and Biological Defense | Phase ISTTR | 2016 | $150.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.